BRPI0922010A2 - dervivados de quinazolina como antagonistas receptores de nk3 - Google Patents
dervivados de quinazolina como antagonistas receptores de nk3Info
- Publication number
- BRPI0922010A2 BRPI0922010A2 BRPI0922010A BRPI0922010A BRPI0922010A2 BR PI0922010 A2 BRPI0922010 A2 BR PI0922010A2 BR PI0922010 A BRPI0922010 A BR PI0922010A BR PI0922010 A BRPI0922010 A BR PI0922010A BR PI0922010 A2 BRPI0922010 A2 BR PI0922010A2
- Authority
- BR
- Brazil
- Prior art keywords
- receptor antagonists
- quinazoline derivatives
- quinazoline
- derivatives
- antagonists
- Prior art date
Links
- 102000002003 Neurokinin-3 Receptors Human genes 0.000 title 1
- 108010040716 Neurokinin-3 Receptors Proteins 0.000 title 1
- 125000002294 quinazolinyl group Chemical class N1=C(N=CC2=CC=CC=C12)* 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08169162 | 2008-11-14 | ||
| PCT/EP2009/064604 WO2010054968A1 (en) | 2008-11-14 | 2009-11-04 | Quinazoline derivatives as nk3 receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0922010A2 true BRPI0922010A2 (pt) | 2015-12-15 |
Family
ID=41395938
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0922010A BRPI0922010A2 (pt) | 2008-11-14 | 2009-11-04 | dervivados de quinazolina como antagonistas receptores de nk3 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8318749B2 (pt) |
| EP (1) | EP2346848B1 (pt) |
| JP (1) | JP5362839B2 (pt) |
| KR (1) | KR101337163B1 (pt) |
| CN (1) | CN102216283B (pt) |
| AU (1) | AU2009315761A1 (pt) |
| BR (1) | BRPI0922010A2 (pt) |
| CA (1) | CA2737587C (pt) |
| ES (1) | ES2404076T3 (pt) |
| IL (1) | IL211803A0 (pt) |
| MX (1) | MX2011004295A (pt) |
| WO (1) | WO2010054968A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013070852A2 (en) * | 2011-11-08 | 2013-05-16 | Emory University | Compounds and compositions used to epigenetically transform cells and methods related thereto |
| AR123746A1 (es) | 2018-12-11 | 2023-01-11 | Suzano Papel E Celulose S A | Composición de fibras, uso de la referida composición y artículo que la comprende |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1981424A (en) * | 1934-06-27 | 1934-11-20 | Excel Auto Radiator Company | Heat exchange device |
| DK159079A (da) * | 1978-05-18 | 1979-11-19 | Pfizer | Fremgangsmaade til fremstilling af derivater af 4-amino-2-piperidinoquinazolin eller syreadditionssalte deraf |
| FI800481A7 (fi) * | 1980-02-19 | 1981-01-01 | Orion Yhtymae Oy | Menetelmä substituoitujen asyylipiperiidiinien valmistamiseksi. |
| NZ287413A (en) | 1994-05-24 | 1998-02-26 | Hoffmann La Roche | Dioxo derivatives of triazoloquinazoline, isoxazoloquinoline, pyrazoloquinoline and analogs, medicaments |
| GB9526546D0 (en) * | 1995-12-23 | 1996-02-28 | Pfizer Ltd | Compounds useful in therapy |
| CN1205693A (zh) * | 1995-12-23 | 1999-01-20 | 辉瑞研究开发公司 | 有治疗作用的喹啉和喹唑啉化合物 |
| GB0109122D0 (en) * | 2001-04-11 | 2001-05-30 | Smithkline Beecham Spa | Novel compounds |
| US7713983B2 (en) * | 2003-03-03 | 2010-05-11 | Vertex Pharmaceuticals Incorporated | Quinazolines useful as modulators of ion channels |
| CL2004000409A1 (es) | 2003-03-03 | 2005-01-07 | Vertex Pharma | Compuestos derivados de 2-(cilo sustituido)-1-(amino u oxi sustituido)-quinazolina, inhibidores de canales ionicos de sodio y calcio dependientes de voltaje; composicion farmaceutica; y uso del compuesto en el tratamiento de dolor agudo, cronico, neu |
| WO2008131779A1 (en) * | 2007-04-26 | 2008-11-06 | H. Lundbeck A/S | Isoquinolinone derivatives as nk3 antagonists |
-
2009
- 2009-11-04 JP JP2011535967A patent/JP5362839B2/ja not_active Expired - Fee Related
- 2009-11-04 EP EP09744414A patent/EP2346848B1/en not_active Not-in-force
- 2009-11-04 BR BRPI0922010A patent/BRPI0922010A2/pt not_active IP Right Cessation
- 2009-11-04 AU AU2009315761A patent/AU2009315761A1/en not_active Abandoned
- 2009-11-04 WO PCT/EP2009/064604 patent/WO2010054968A1/en active Application Filing
- 2009-11-04 CA CA2737587A patent/CA2737587C/en not_active Expired - Fee Related
- 2009-11-04 MX MX2011004295A patent/MX2011004295A/es active IP Right Grant
- 2009-11-04 ES ES09744414T patent/ES2404076T3/es active Active
- 2009-11-04 KR KR1020117010753A patent/KR101337163B1/ko not_active Expired - Fee Related
- 2009-11-04 CN CN2009801451532A patent/CN102216283B/zh not_active Expired - Fee Related
- 2009-11-09 US US12/614,474 patent/US8318749B2/en not_active Expired - Fee Related
-
2011
- 2011-03-17 IL IL211803A patent/IL211803A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2011004295A (es) | 2011-05-23 |
| JP5362839B2 (ja) | 2013-12-11 |
| JP2012508266A (ja) | 2012-04-05 |
| US20100125078A1 (en) | 2010-05-20 |
| ES2404076T3 (es) | 2013-05-23 |
| EP2346848A1 (en) | 2011-07-27 |
| IL211803A0 (en) | 2011-06-30 |
| US8318749B2 (en) | 2012-11-27 |
| AU2009315761A1 (en) | 2010-05-20 |
| CA2737587A1 (en) | 2010-05-20 |
| KR101337163B1 (ko) | 2013-12-05 |
| KR20110075017A (ko) | 2011-07-05 |
| CN102216283A (zh) | 2011-10-12 |
| CA2737587C (en) | 2016-08-09 |
| WO2010054968A1 (en) | 2010-05-20 |
| EP2346848B1 (en) | 2013-02-27 |
| CN102216283B (zh) | 2013-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2200033I1 (hu) | CGRP receptor antagonisták | |
| BRPI0821141A2 (pt) | Derivados de heteroarila como antagonistas do receptor de orexina | |
| BRPI0817245A2 (pt) | Derivados e quinolina como antagonistas receptores de 5ht5a | |
| BRPI0909157A2 (pt) | compostos heterocíclicos como antagonistas de receptores de adenosina | |
| BRPI0810462A2 (pt) | Derivados de quinolina-carboxamida como antagonistas de p2y12 | |
| BRPI0717023A2 (pt) | Tiazol pirazolopirimidina como antagonistas do receptor de crf1 | |
| EP2244575A4 (en) | ANTAGONISTS OF THE ANGIOTENSIN II RECEPTOR | |
| EP2350060A4 (en) | Melanocortin receptor AGONISTS | |
| BRPI0923512A2 (pt) | antagonistas de receptores de ácido lisofosfatídico | |
| BRPI0813768A2 (pt) | Derivados de benzazepina úteis como antagonistas de vasopressina | |
| BRPI0919844A2 (pt) | compostos de azaindazol como antagonistas do receptor ccr1 | |
| BRPI0913930A2 (pt) | antagonistas de receptores de prostaglandinas d2 | |
| IL208466A0 (en) | Isoquinolinone derivatives as nk3 antagonists | |
| BRPI0717937A2 (pt) | Compostos de pirazona como antagonistas do receptor mineralocorticóide | |
| BRPI0910118A2 (pt) | antagonistas de receptores do glucagon | |
| BRPI0814767A2 (pt) | Derivados de monoamida como antagonistas do receptor de orexina | |
| BRPI0814806A2 (pt) | Pirazinas substituídas como antagonistas de cb1 | |
| BRPI0817061A2 (pt) | Derivados de pirrolidinilalquilisoquinolinona e -isoindolinona como antagonistas de histamina-3 | |
| BRPI0815674A2 (pt) | Aril-éter de pirrolidina como antagonista de receptor de nk3 | |
| EP2254413A4 (en) | IMIDAZOBENZAZEPIN-CGRP receptor antagonists | |
| SMT201300020B (it) | Derivati di isochinolinone come antagonisti dei recettori nk3 | |
| BRPI0720078A2 (pt) | 2-aminoquinolinas como antagonistas de receptores de 5-ht(5a) | |
| BRPI0915834A2 (pt) | 6-(1-piperazinil)-piridazinas substituídas como antagonistas do receptor de 5-ht6 | |
| BRPI1013617A2 (pt) | derivados de piperidina como antagonistas de receptor de nk3 | |
| BR112012003976A2 (pt) | antagonistas de receptor glyt1 carbocíclico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2538 DE 27-08-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |